ILA.AX · ISLAND PHARMACEUTICALS LIMITED
Australia · RS rating 53 · As of 2026-10-14
| Price | 0.38 AUD |
|---|---|
| 1-day change | +0.7% |
| RS rating (overall / 1M / 3M / 12M) | 53 / 25 / 41 / 72 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 29 / 27 / 23 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +33.3% |
| Market cap (USD) | $75.2M |